Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

View:
Post by Marky1 on Jan 10, 2021 8:21am

Cash on Hand

In 2020. Pfizer had 22B$ liquid money ...140% increase over 2019...I'm sure that for 2021 this will increase substantially because of their COVID vaccine

Bayer on the other hand has 18B$ in the bank...196% increase over 2019

as Crow has said...4B$ for ATE is very realistic 
GLTA
Comment by ABCs123s on Jan 10, 2021 8:37am
Yeah realistically cheap
Comment by IrishCanuck on Jan 10, 2021 8:57am
Very enticing. Something I've been thinking about lately though if anyone has opions is what happens if a company buys ONLY Otenaproxesul... I want the entire company being bought because 352 and others drugs hugely increases the value. Let's say Otena is 4 billion, Antibe receives 4 billion, not like they're going to issue a special one time dividend right? That doesn't happen ...more  
Comment by MrMugsy on Jan 10, 2021 9:26am
I'm hoping that ATE already sees at least one opportunity to partner wth 3 or 4 companies to bring the first product to market.  Maybe a few options already exist.  A deal(s) with some upfront fees, milestone payments and a double digit royalty.  This is a good starting point as they chat with others and with Big Pharma. Big Pharma would need to come through with a better offer ...more  
Comment by Marky1 on Jan 10, 2021 10:09am
Mr. Mugsy... I love your calmness, your perfect logic! You are 100% correct...The company has to approach their futur in a calm, intelligent, well thought out manner! with the addition of Dr. Stauffer and Dr. Haut...I think that we have the right team, at the right time! 2021 is a year that all of us will remember!
Comment by Marky1 on Jan 10, 2021 10:04am
At 9B$ that's 180$ a share...would be nice, but for me 80$ would be more realistic...
Comment by MikeStock on Jan 10, 2021 12:41pm
I too would love for someone to buy 346, 352 and 340 and make the decision for me about how much the shares are worth and put this all to bed one great morning. Anything south of $6B CAD for the lot and I'm laughing for the rest of my life. 
Comment by 3burtc on Jan 10, 2021 1:15pm
Has Dan made any comments recently to what the company is worth? We know that revenue will average 2.8 billion per year, otezla sold for 8 times revenue.
Comment by themagicbox on Jan 10, 2021 1:22pm
in his latest biopub he said its worth x2-x4 its current amount. Best to keep expectation graded. Dan had mentioned 75% likelihood partnership vs 25% buyout. I'm very bullish on ATE but I've disappointed many times before. Hopefully the corporate update is next week to give indication of the direction we're heading towards. 
Comment by 3burtc on Jan 10, 2021 1:43pm
That's incorrect! He said it should be trading 2 to 4 times more. He never said it was worth that. I think 346 is worth 20 billion dollars.
Comment by 3burtc on Jan 10, 2021 1:55pm
Amgen Completes Acquisition Of Otezla® (apremilast) Differentiated Therapy Strengthens Amgen's Long-Standing Expertise in Inflammation   NEWS PROVIDED BY Amgen  Nov 21, 2019, 06:21 ET   THOUSAND OAKS, Calif., Nov. 21, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN ...more  
Comment by themagicbox on Jan 10, 2021 2:20pm
I'm not going to argue the semantics of value vs trading. Lets see if Dan actually delivers either a partnership or buyout. Dan has never failed to disappoint The last time they said they have "cash on hand", they still ended up diluting. That risk still exists. For some this will be another entry point, for others theyre going to eat the dilution.  Hopefully this new hire can ...more  
Comment by moosepenny on Jan 10, 2021 2:45pm
Thank you for your perspective. We're getting a little greedy here, which isn't good for anyone. We will know what happens when it happens if it happens. Until then, hold tight.
Comment by Marky1 on Jan 10, 2021 2:46pm
I respectfully disagree with you Magic...I don't believe that ATE is dead money for the next 6 months. With the signing of Haut and Stauffer...and taking on Stern IR...I think negotiations are well underway for a Partnership ( likely ) or takeover ( doubtful) I feel that starting tomorrow, we will be headed upwards....We just need catalysts to start the game , If Repare can be a. 2B$ CDN ...more  
Comment by themagicbox on Jan 10, 2021 5:05pm
I applaud your optimism and input Marky. I sincerely hope that you're right and I'm wrong. My pessimism is primarily with Dan, overall. And you made some very valid points about Haut and Stauffer. Heres to next week. Cheers.
Comment by 3burtc on Jan 10, 2021 5:32pm
Hey man which planet do you live on? I would suggest that next time you pick a planet that has oxygen. We all owe Dan a debt of gratitude for wealth that's coming our way. Stop it, grow up or get out!
Comment by Marky1 on Jan 10, 2021 5:40pm
Totally agree 3 Burt.....Just look at who he's brought in to the company...Stauffer, Haut, Stern and others! IMHO. Dan is doing a fantastic job! And I'm proud to have him lead the company
Comment by Inthepez on Jan 10, 2021 8:08pm
I guess a reasonable conversation isn’t possible with likes of you. You’re practically opposite version of Duster the dumpster.  I think you forgot that Dan was: 1- the one who spearheaded the cita acquisition that’s bleeding money (thank the good old Trudeau dollars for keep cita somewhat in check) 2-kept saying “cash on hand” to fund the upcoming phases only to dilute midway  3 ...more  
Comment by themagicbox on Jan 10, 2021 9:26pm
Well said Pez. I usually ignore people wiho are 'extreme' like that. Even presenting basic facts will seem like presenting pearls before swine.
Comment by 3burtc on Jan 10, 2021 10:53pm
I shouldn't get down to your level but liar, liar pants on fire. You bashers always show up at just the right time. Thanks , feeling more positive now.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities